BCL6 and hematopoietic and lymphoid system neoplasm: BCL6, a transcriptional repressor linked to blood cancers and solid tumors, suppresses tumor suppressor genes while promoting those involved in cell proliferation and immune evasion, contributing to chemotherapy resistance [47,48,49].